Literature DB >> 1456298

Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3).

N Tommerup1, C B van der Hagen, A Heiberg.   

Abstract

During a systematic chromosomal survey of 7 unrelated patients with Rubinstein-Taybi syndrome, an apparently balanced de novo reciprocal translocation, t(7;16)(q34;p13.3), was detected in an affected boy. The involvement of the region 16p13.3 coincides with the position of one of the breakpoints in another de novo reciprocal translocation associated with Rubinstein-Taybi syndrome, suggesting that a locus for this syndrome maps to 16p13.3.

Entities:  

Mesh:

Year:  1992        PMID: 1456298     DOI: 10.1002/ajmg.1320440223

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

Review 1.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

2.  Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.

Authors:  F Petrij; H G Dauwerse; R I Blough; R H Giles; J J van der Smagt; R Wallerstein; P D Maaswinkel-Mooy; C D van Karnebeek; G J van Ommen; A van Haeringen; J H Rubinstein; H M Saal; R C Hennekam; D J Peters; M H Breuning
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

3.  Rubinstein-taybi syndrome: a female patient with a de novo reciprocal translocation t(2; 16)(q36.3; p13.3) and dysgranulopoiesis.

Authors:  Leuridan Cavalcante Torres; Maria de Lourdes Lopes Chauffaille; Thomaz Pileggi Delboni; Thelma Suely Okay; Magda Carneiro-Sampaio; Sofia Sugayama
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 4.  Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Authors:  Silvia Spena; Cristina Gervasini; Donatella Milani
Journal:  J Pediatr Genet       Date:  2015-09-28

5.  Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project.

Authors:  Anne W Higgins; Fowzan S Alkuraya; Amy F Bosco; Kerry K Brown; Gail A P Bruns; Diana J Donovan; Robert Eisenman; Yanli Fan; Chantal G Farra; Heather L Ferguson; James F Gusella; David J Harris; Steven R Herrick; Chantal Kelly; Hyung-Goo Kim; Shotaro Kishikawa; Bruce R Korf; Shashikant Kulkarni; Eric Lally; Natalia T Leach; Emma Lemyre; Janine Lewis; Azra H Ligon; Weining Lu; Richard L Maas; Marcy E MacDonald; Steven D P Moore; Roxanna E Peters; Bradley J Quade; Fabiola Quintero-Rivera; Irfan Saadi; Yiping Shen; Jay Shendure; Robin E Williamson; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

6.  A chromosomal deletion map of human malformations.

Authors:  C Brewer; S Holloway; P Zawalnyski; A Schinzel; D FitzPatrick
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

Review 7.  Epigenetics and Human Disease.

Authors:  Huda Y Zoghbi; Arthur L Beaudet
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-02-01       Impact factor: 10.005

8.  Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome, GH deficiency, Arnold Chiari malformation and pituitary hypoplasia.

Authors:  Pierluigi Marzuillo; Anna Grandone; Ruggero Coppola; Domenico Cozzolino; Adalgisa Festa; Federica Messa; Caterina Luongo; Emanuele Miraglia Del Giudice; Laura Perrone
Journal:  BMC Med Genet       Date:  2013-02-23       Impact factor: 2.103

Review 9.  Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Authors:  Donatella Milani; Francesca Maria Paola Manzoni; Lidia Pezzani; Paola Ajmone; Cristina Gervasini; Francesca Menni; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2015-01-20       Impact factor: 2.638

Review 10.  Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Authors:  Julien Van Gils; Frederique Magdinier; Patricia Fergelot; Didier Lacombe
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.